Publications - WifOR Institute

Latest publications

Journal publication

Antonia Quell, Dr. Richard Scholz

01/2022

A procurement tool for streamlined Input-Output sustainability assessment

Method paper

Dr. Richard Scholz, Dr. Nora Albu, Dr. Daniel Croner, Dr. Zarko Kalamov, Lukas Mai, Dr. Silvia Forin, Jasmin Tesch, Tabea Dorndorf

08/2023

WifOR Impact Valuation

Study

Sarah Hofmann, Jennifer Branner, Dr. Malina Müller, In collaboration with Dr. Laurie Brown (University of Canberra)

01/2023

Assessing the Value of Medicines Beyond Patients’ Health Benefits

Library

Journal publication

2021

Are medicines more greenhouse gas intensive than cars? Comment to Belkhir, L., Elmeligi, A., 2019: Carbon footprint of the global pharmaceutical industry and relative impact of its major players

Dr. Richard Scholz, Silvia Forin
Journal publication

2021

The societal impact of early intensified treatment in patients with type 2 diabetes mellitus

Dr. Eva Levi, Dr. Mathias Kappel, Dr. Platon Peristeris, Foteini Tsotra, In collaboration with Ankur Malhotra (Novartis), In collaboration with Giovanni Bader (Novartis), In collaboration with Nicola Lister (Novartis), Prof. Dr. Dennis Ostwald
Journal publication

2021

The Societal Economic Impact of Secukinumab in First‑Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open‑Cohort Simulation

Ahmed Seddik, Ahmed Seddik, Foteini Tsotra, In collaboration with Nima Melzer (Novartis), Prof. Dr. Dennis Ostwald
Journal publication

2021

Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort Approach

Ahmed Seddik, Ahmed Seddik, Claudio Schneider, In collaboration with Dr. Jasper Huels (Novartis), In collaboration with Dr. Zaza Katsarava (University of Duisburg-Essen), In collaboration with Sara Schramm (University of Duisburg-Essen), Prof. Dr. Dennis Ostwald
Journal publication

2021

A Review of Current Approaches to Defining and Valuing Innovation in Health Technology Assessment

Dr. Arpit Misra, Hannah Lintener, Jennifer Branner, Sarah Hofmann
Journal publication

2021

The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany

Sarah Hofmann, Sebastian Himmler, Prof. Dr. Dennis Ostwald, In collaboration with Ulrich Dünziger (Roche), In collaboration with Aino Launonen (Roche), In collaboration with Per-Olaf Thuresson

Latest publications

A procurement tool for streamlined Input-Output sustainability assessment

WifOR Impact Valuation

Assessing the Value of Medicines Beyond Patients’ Health Benefits

Library

Are medicines more greenhouse gas intensive than cars? Comment to Belkhir, L., Elmeligi, A., 2019: Carbon footprint of the global pharmaceutical industry and relative impact of its major players

The societal impact of early intensified treatment in patients with type 2 diabetes mellitus

The Societal Economic Impact of Secukinumab in First‑Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open‑Cohort Simulation

A Review of Current Approaches to Defining and Valuing Innovation in Health Technology Assessment

The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany

Interested in our newsletter?

Interested in our newsletter?